Healthy volunteer study of a new test drug (EQ504)
Part of Digestive system clinical trials.
This early-stage study tests a new drug called EQ504 in healthy volunteers to see how safe it is and how the body handles it. Participants receive either the drug or a placebo (inactive substance), and the study helps determine the right dose for future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your body mass index (BMI) must be between 18 and 32, and you must weigh at least 55 kg (about 121 pounds).
- You must be in good general health with no major medical problems.
- You must have veins suitable for blood draws.
- You must not have a history of alcohol or drug abuse, smoke more than 5 nicotine products a month (or be willing to stop smoking for 7 days before and during the study), or have certain infections like HIV, hepatitis B, or hepatitis C.
- You must not have taken any investigational drugs or used certain medications or vaccines within specific time frames before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.